Literature DB >> 22570239

Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation.

Gianluca Aguiari1, Fabiana Bizzarri, Anna Bonon, Alessandra Mangolini, Eros Magri, Massimo Pedriali, Patrizia Querzoli, Stefan Somlo, Peter C Harris, Luigi Catizone, Laura Del Senno.   

Abstract

In autosomal dominant polycystic kidney disease (ADPKD), renal cyst development and enlargement, as well as cell growth, are associated with alterations in several pathways, including cAMP and activator protein 1 (AP1) signalling. However, the precise mechanism by which these molecules stimulate cell proliferation is not yet fully understood. We now show by microarray analysis, luciferase assay, mutagenesis, and chromatin immunoprecipitation that CREB and AP1 contribute to increased expression of the amphiregulin gene, which codifies for an epidermal growth factor-like peptide, in ADPKD cystic cells, thereby promoting their cell growth. Increased amphiregulin (AR) expression was associated with abnormal cell proliferation in both PKD1-depleted and -mutated epithelial cells, as well as primary cystic cell lines isolated from ADPKD kidney tissues. Consistently, normal AR expression and proliferation were re-established in cystic cells by the expression of a mouse full-length PC1. Finally, we show that anti-AR antibodies and inhibitors of AP1 are able to reduce cell proliferation in cystic cells by reducing AR expression and EGFR activity. AR can therefore be considered as one of the key activators of the growth of human ADPKD cystic cells and thus a new potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22570239      PMCID: PMC4028691          DOI: 10.1007/s00109-012-0902-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  36 in total

Review 1.  Polycystic kidney disease.

Authors:  Patricia D Wilson
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

2.  A plethora of epidermal growth factor-like proteins in polycystic kidneys.

Authors:  Patricia D Wilson
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

3.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.

Authors:  T Hai; T Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.

Authors:  G D Plowman; G S Whitney; M G Neubauer; J M Green; V L McDonald; G J Todaro; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.

Authors:  Mahmoud Loghman-Adham; Surya M Nauli; Carlos E Soto; Barbara Kariuki; Jing Zhou
Journal:  Am J Physiol Renal Physiol       Date:  2003-05-06

6.  Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells.

Authors:  S Hanazawa; A Takeshita; S Amano; T Semba; T Nirazuka; H Katoh; S Kitano
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

7.  Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.

Authors:  Franck A Belibi; Gail Reif; Darren P Wallace; Tamio Yamaguchi; Lincoln Olsen; Hong Li; George M Helmkamp; Jared J Grantham
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

8.  EGF-related growth factors in the pathogenesis of murine ARPKD.

Authors:  Katherine MacRae Dell; Raghad Nemo; William E Sweeney; Ellis D Avner
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

9.  The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types.

Authors:  C Christian Johansson; Arne Yndestad; Jorrit M Enserink; Anne H Ree; Pål Aukrust; Kjetil Taskén
Journal:  Endocrinology       Date:  2004-07-29       Impact factor: 4.736

10.  Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD.

Authors:  J Du; P D Wilson
Journal:  Am J Physiol       Date:  1995-08
View more
  16 in total

1.  Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.

Authors:  Lucia de Stephanis; Anna Bonon; Katia Varani; Giovanni Lanza; Roberta Gafà; Paolo Pinton; Monika Pema; Stefan Somlo; Alessandra Boletta; Gianluca Aguiari
Journal:  Clin Exp Nephrol       Date:  2016-06-09       Impact factor: 2.801

Review 2.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 3.  Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 4.  Role of calcium in polycystic kidney disease: From signaling to pathology.

Authors:  Alessandra Mangolini; Lucia de Stephanis; Gianluca Aguiari
Journal:  World J Nephrol       Date:  2016-01-06

Review 5.  Novel therapeutic approaches to autosomal dominant polycystic kidney disease.

Authors:  Wells B LaRiviere; Maria V Irazabal; Vicente E Torres
Journal:  Transl Res       Date:  2014-11-13       Impact factor: 7.012

6.  A cAMP and CREB-mediated feed-forward mechanism regulates GSK3β in polycystic kidney disease.

Authors:  Vijayakumar R Kakade; Shixin Tao; Madhumitha Rajagopal; Xia Zhou; Xiaogang Li; Alan S L Yu; James P Calvet; Pankaj Pandey; Reena Rao
Journal:  J Mol Cell Biol       Date:  2016-05-04       Impact factor: 6.216

Review 7.  Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.

Authors:  Mitchell I Parker; Anna S Nikonova; Danlin Sun; Erica A Golemis
Journal:  Cell Signal       Date:  2019-12-09       Impact factor: 4.315

Review 8.  The epidermal growth factor receptor pathway in chronic kidney diseases.

Authors:  Laura R Harskamp; Ron T Gansevoort; Harry van Goor; Esther Meijer
Journal:  Nat Rev Nephrol       Date:  2016-07-04       Impact factor: 28.314

9.  Conditional mesenchymal disruption of pkd1 results in osteopenia and polycystic kidney disease.

Authors:  Ni Qiu; Zhousheng Xiao; Li Cao; Valentin David; Leigh Darryl Quarles
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

10.  Anthrapyrazolone analogues intercept inflammatory JNK signals to moderate endotoxin induced septic shock.

Authors:  Karothu Durga Prasad; Jamma Trinath; Ansuman Biswas; Kanagaraj Sekar; Kithiganahalli N Balaji; Tayur N Guru Row
Journal:  Sci Rep       Date:  2014-11-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.